headlines 20th June to 23rd July 2010
Tumbles on Failure of Cancer Drug Trial: Biotech's Latest Mishaps.’
Bullfax. 20 June 2010.
pulls leukemia drug from U.S. market.
Drugmaker Pfizer Inc is pulling a decade-old leukemia medicine off the U.S.
market after a study found a higher death rate and no benefit for patients.’
Reuters. 21 June 2010.
(gemtuzumab ozogamicin): Market Withdrawal.'
FDA Medwatch. 21 June 2010.
Suspends Trial of Tanezumab for Osteoarthritis Pain at U.S. Request’
Bloomberg. 23 June 2010.
Settles Nearly 200 Paxil Birth Defect Lawsuits.’
Pharmalot. 23 June 2010.
shares fall over problems with pain drug.'
Bloomberg Business Week. 24 June 2010
regulators probe risks of blood pressure drugs.'
Reuters. 25 June 2010
raises questions over wider use of statins.'
Reuters. 28 June 2010
Effient Tied to More Cancer Risk Than Plavix.'
Bloomberg Business Week. 28 June 2010
to fight $8M Fosamax verdict.
Merck has lost its first Fosamax jury trial. A New York jury awarded
$8 million in damages to plaintiff Shirley Boles, who claimed her osteonecrosis
of the jaw was caused by the bone-building drug.’
Fiercepharma. 28 June 2010
FDA probes possible risks of Lilly drug, others. Lilly's Effient,
Sanofi's Multaq under review.'
Reuters. 30 June 2010
is linked to heart failure, stroke, and death.'
BMJ. 1 July 2010, JAMA 2010; doi:10.1001/jama.2010.920. Arch Intern
Gel Trial Ends After Heart Issue’
New York Times. 5 July 2010.
big setback for XenoPort: Migraine drug fails test.’
Mercury News. 7 July 2010.
on Liver Injury with Propylthiouracil.’
FDA. July 2010.
Xenoport migraine drug fails, shares fall.’
Reuters. 7 July 2010.
(leflunomide): Boxed Warning - Risk of Severe Liver Injury.’
FDA. 13 July 2010.
pays $460 million to resolve Avandia suits. It was facing more than 13,000
claims alleging that it hid the diabetes drug's heart-attack risk.’
Philadelphia Inquirer. 14 July 2010.
‘Glaxosmithkline to settle claims. GlaxoSmithKline will post a record
£1.57billion legal charge during the second quarter
GlaxoSmithKline will post a record £1.57billion legal charge during
the second quarter to settle a host of claims relating to blockbuster
diabetes pill Avandia and depression treatment Paxil.’
Daily Express. 16 July 2010.
panel rejects diet drug.’s
Post-Gazette. 16 July 2010.
Breast Cancer Drug Fails FDA Test. New Study Shows Little Result Compared
To Chemotherapy Alone.’ FoxReno. 19 July 2010‘Pfizer forced
to halt pain drug trials.’
Inpharm. 20 July 2010
says settles some Paxil birth-defect cases.’
Reuters. 20 July 2010
‘Trials of 'unsafe' drug for diabetes stopped.’
Times of India. 23 July 2010.
the new VIN website: http://www.vivisectioninformation.com
Information for abolition